Celgene's partnership with Bluebird & Juno

[anonymous]

Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017.

I think it's an advantage for all the three companies involved; especially for Bluebird Bio.

 

[anonymous]

Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017.

I think it's an advantage for all the three companies involved; especially for Bluebird Bio.

ASCO ‘18 not so impressive but very tough patient population. How will Wall Street react?

 

[anonymous]

Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017.

I think it's an advantage for all the three companies involved; especially for Bluebird Bio.

ASH 2017???

 

[anonymous]

bluebird is a disorganized one trick pony with a extremely expensive treatment. Other biotech companies are catching up and everyone knows it